Genedx Holdings Corp Stock Price Prediction
| WGS Stock | 78.58 6.51 9.03% |
Oversold Vs Overbought
68
Oversold | Overbought |
EPS Estimate Next Quarter (0.16) | EPS Estimate Current Year (0.33) | EPS Estimate Next Year 0.49 | Wall Street Target Price 80.8333 | EPS Estimate Current Quarter (0.21) |
Using GeneDx Holdings hype-based prediction, you can estimate the value of GeneDx Holdings Corp from the perspective of GeneDx Holdings response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in GeneDx Holdings to buy its stock at a price that has no basis in reality. In that case, they are not buying GeneDx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
GeneDx Holdings after-hype prediction price | USD 71.41 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
GeneDx |
GeneDx Holdings After-Hype Price Prediction Density Analysis
As far as predicting the price of GeneDx Holdings at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in GeneDx Holdings or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of GeneDx Holdings, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
GeneDx Holdings Estimiated After-Hype Price Volatility
In the context of predicting GeneDx Holdings' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on GeneDx Holdings' historical news coverage. GeneDx Holdings' after-hype downside and upside margins for the prediction period are 63.88 and 78.94, respectively. We have considered GeneDx Holdings' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
GeneDx Holdings is somewhat reliable at this time. Analysis and calculation of next after-hype price of GeneDx Holdings Corp is based on 3 months time horizon.
GeneDx Holdings Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as GeneDx Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GeneDx Holdings backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with GeneDx Holdings, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.34 | 7.53 | 0.66 | 0.12 | 11 Events / Month | 7 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
78.58 | 71.41 | 0.92 |
|
GeneDx Holdings Hype Timeline
On the 22nd of November GeneDx Holdings Corp is traded for 78.58. The entity has historical hype elasticity of -0.66, and average elasticity to hype of competition of -0.12. GeneDx is forecasted to decline in value after the next headline, with the price expected to drop to 71.41. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -0.92%, whereas the daily expected return is at this time at 1.34%. The volatility of related hype on GeneDx Holdings is about 8165.06%, with the expected price after the next announcement by competition of 78.46. About 18.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 3.09. GeneDx Holdings Corp had not issued any dividends in recent years. The entity had 1:33 split on the 4th of May 2023. Considering the 90-day investment horizon the next forecasted press release will be in about 11 days. Check out GeneDx Holdings Basic Forecasting Models to cross-verify your projections.GeneDx Holdings Related Hype Analysis
Having access to credible news sources related to GeneDx Holdings' direct competition is more important than ever and may enhance your ability to predict GeneDx Holdings' future price movements. Getting to know how GeneDx Holdings' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how GeneDx Holdings may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PRVA | Privia Health Group | 1.41 | 9 per month | 2.14 | 0.02 | 4.30 | (3.55) | 15.04 | |
| HSTM | HealthStream | (1.65) | 8 per month | 1.30 | 0.05 | 2.33 | (2.00) | 10.49 | |
| CERT | Certara | (0.64) | 10 per month | 0.00 | (0.21) | 3.12 | (4.01) | 15.96 | |
| NRC | National Research Corp | (0.02) | 9 per month | 0.00 | (0.09) | 4.51 | (4.72) | 13.17 | |
| DH | Definitive Healthcare Corp | (0.01) | 9 per month | 2.42 | (0.04) | 4.37 | (4.00) | 13.20 | |
| EUDA | EUDA Health Holdings | 0.07 | 2 per month | 6.73 | 0.01 | 9.70 | (10.50) | 26.33 | |
| ACON | Aclarion | (0.01) | 7 per month | 0.00 | (0.04) | 11.11 | (10.00) | 35.83 | |
| HCTI | Healthcare Triangle | 0.01 | 3 per month | 8.21 | 0.11 | 10.34 | (17.65) | 131.06 | |
| FOXO | FOXO Technologies | 0.01 | 3 per month | 8.61 | 0.12 | 34.29 | (7.14) | 509.71 |
GeneDx Holdings Additional Predictive Modules
Most predictive techniques to examine GeneDx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for GeneDx using various technical indicators. When you analyze GeneDx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About GeneDx Holdings Predictive Indicators
The successful prediction of GeneDx Holdings stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as GeneDx Holdings Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of GeneDx Holdings based on analysis of GeneDx Holdings hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to GeneDx Holdings's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to GeneDx Holdings's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 5.12 | 5.68 | 13.86 | 14.56 | Days Of Inventory On Hand | 53.37 | 19.08 | 22.57 | 40.43 |
Story Coverage note for GeneDx Holdings
The number of cover stories for GeneDx Holdings depends on current market conditions and GeneDx Holdings' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that GeneDx Holdings is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about GeneDx Holdings' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
GeneDx Holdings Short Properties
GeneDx Holdings' future price predictability will typically decrease when GeneDx Holdings' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of GeneDx Holdings Corp often depends not only on the future outlook of the potential GeneDx Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GeneDx Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 24.3 M | |
| Cash And Short Term Investments | 130.1 M |
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.